Merck & Co. (MRK)
(Real Time Quote from BATS)
$131.22 USD
+0.50 (0.38%)
Updated Apr 26, 2024 12:00 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7,093 | 13,192 | 8,096 | 8,062 | 10,450 |
Receivables | 10,349 | 9,450 | 9,230 | 7,851 | 6,778 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 6,358 | 5,911 | 5,953 | 6,310 | 5,978 |
Other Current Assets | 8,368 | 7,169 | 6,987 | 5,541 | 4,277 |
Total Current Assets | 32,168 | 35,722 | 30,266 | 27,764 | 27,483 |
Net Property & Equipment | 23,051 | 21,422 | 19,279 | 17,986 | 15,053 |
Investments & Advances | 252 | 1,015 | 370 | 785 | 1,469 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 39,208 | 41,473 | 44,197 | 34,842 | 33,621 |
Deposits & Other Assets | 11,996 | 9,528 | 11,582 | 10,211 | 6,771 |
Total Assets | 106,675 | 109,160 | 105,694 | 91,588 | 84,397 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 1,372 | 1,946 | 2,412 | 6,431 | 3,610 |
Accounts Payable | 3,922 | 4,264 | 4,609 | 4,594 | 3,738 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 15,766 | 14,159 | 13,859 | 13,053 | 12,549 |
Income Taxes Payable | 2,649 | 1,986 | 1,224 | 1,575 | 736 |
Other Current Liabilities | 1,985 | 1,884 | 1,768 | 1,674 | 1,587 |
Total Current Liabilities | 25,694 | 24,239 | 23,872 | 27,327 | 22,220 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 871 | 1,795 | 3,441 | 1,015 | 1,470 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 33,683 | 28,745 | 30,690 | 25,360 | 22,736 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8,792 | 8,323 | 9,434 | 12,482 | 11,970 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 69,040 | 63,102 | 67,437 | 66,184 | 58,396 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,788 | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | 44,509 | 44,379 | 44,238 | 39,588 | 39,660 |
Retained Earnings | 53,895 | 61,081 | 53,696 | 47,362 | 46,602 |
Other Equity | -5,107 | -4,701 | -4,356 | -6,547 | -6,099 |
Treasury Stock | 57,450 | 56,489 | 57,109 | 56,787 | 55,950 |
Total Shareholder's Equity | 37,635 | 46,058 | 38,257 | 25,404 | 26,001 |
Total Liabilities & Shareholder's Equity | 106,675 | 109,160 | 105,694 | 91,588 | 84,397 |
Total Common Equity | 37,635 | 46,058 | 38,257 | 25,404 | 26,001 |
Shares Outstanding | 2,534.00 | 2,535.40 | 2,527.60 | 2,530.00 | 2,545.90 |
Book Value Per Share | 14.85 | 18.17 | 15.14 | 10.04 | 10.21 |
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 7,093 | 8,773 | 6,378 | 10,387 |
Receivables | NA | 10,349 | 10,394 | 11,030 | 10,415 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 6,358 | 6,131 | 5,930 | 5,863 |
Other Current Assets | NA | 8,368 | 6,656 | 6,639 | 6,737 |
Total Current Assets | NA | 32,168 | 31,954 | 29,977 | 33,402 |
Net Property & Equipment | NA | 23,051 | 22,526 | 22,231 | 21,758 |
Investments & Advances | NA | 252 | 1,306 | 1,214 | 1,290 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 39,208 | 40,382 | 40,860 | 41,066 |
Deposits & Other Assets | NA | 11,996 | 10,559 | 10,187 | 10,280 |
Total Assets | NA | 106,675 | 106,727 | 104,469 | 107,796 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 1,372 | 887 | 2,839 | 2,672 |
Accounts Payable | NA | 3,922 | 3,509 | 3,442 | 3,680 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 15,766 | 14,840 | 13,747 | 13,000 |
Income Taxes Payable | NA | 2,649 | 1,981 | 1,489 | 1,872 |
Other Current Liabilities | NA | 1,985 | 1,877 | 1,877 | 1,907 |
Total Current Liabilities | NA | 25,694 | 23,094 | 23,394 | 23,131 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 871 | 1,018 | 996 | 1,442 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 33,683 | 33,972 | 34,072 | 28,074 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 7,343 | 7,265 | 8,244 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 69,040 | 65,427 | 65,727 | 60,891 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | NA | 44,509 | 44,358 | 44,219 | 44,467 |
Retained Earnings | NA | 53,895 | 57,082 | 54,198 | 62,039 |
Other Equity | NA | -5,107 | -4,862 | -4,851 | -4,812 |
Treasury Stock | NA | 57,450 | 57,066 | 56,612 | 56,577 |
Total Shareholder's Equity | NA | 37,635 | 41,300 | 38,742 | 46,905 |
Total Liabilities & Shareholder's Equity | NA | 106,675 | 106,727 | 104,469 | 107,796 |
Total Common Equity | 0 | 37,635 | 41,300 | 38,742 | 46,905 |
Shares Outstanding | 2,532.60 | 2,534.00 | 2,537.50 | 2,537.40 | 2,538.50 |
Book Value Per Share | 0.00 | 14.85 | 16.28 | 15.27 | 18.48 |